Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Sarepta Therapeutics Inc New

SRPT
99,01
-0,68 (-0,68%)
Ultimo aggiornamento: 19:11:54
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/3/202522:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202522:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202515:00BWSarepta Therapeutics Announces Call for Applications for the..
26/2/202522:05EDGAR2Form 8-K - Current report
26/2/202522:05BWSarepta Therapeutics Announces Fourth Quarter and Full-Year..
14/2/202523:23EDGAR2Form SCHEDULE 13D - General Statement of Acquisition of..
14/2/202519:32EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202514:38EDGAR2Form 8-K - Current report
14/2/202514:30BWSarepta Therapeutics Announces Inaugural $600 Million Senior..
14/2/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202514:30BWSarepta Therapeutics to Announce Fourth Quarter and..
01/2/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202507:00BWSarepta Therapeutics Announces Results from Part 2 of the..
13/1/202518:25EDGAR2Form 8-K - Current report
13/1/202518:25BWSarepta Therapeutics Reports Preliminary* Fourth Quarter and..
06/1/202514:30BWSarepta Therapeutics to Present at the 43rd Annual J.P...
31/12/202422:10BWSarepta Therapeutics Announces Inducement Grants Under..
31/12/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202414:30BWSarepta Therapeutics Completes Enrollment in EMERGENE, a..
17/12/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202423:06EDGAR2Form 144 - Report of proposed sale of securities
07/12/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:18EDGAR2Form 144 - Report of proposed sale of securities
30/11/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202422:10BWSarepta Therapeutics Announces Inducement Grants Under..
26/11/202413:17EDGAR2Form 8-K - Current report
26/11/202413:00BWSarepta Therapeutics Announces Global Licensing and..
21/11/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202415:40EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202416:27EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:05BWSarepta Therapeutics Announces Third Quarter 2024 Financial..
06/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 99,25 Min: 97,91 Max: 101,1354
Chiusura: 99,69

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network